NCT05459012

Brief Summary

Pregnancy may impact treatment adherence in women with asthma. This is a major risk factor for asthma exacerbation, which may have an important impact for both women and the babies. This study aims to evaluate the impact of a targeted patient education action tailored for pregnant women with asthma.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 8, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 14, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

September 19, 2022

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 27, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2023

Completed
Last Updated

November 21, 2023

Status Verified

October 1, 2023

Enrollment Period

9 months

First QC Date

July 8, 2022

Last Update Submit

November 20, 2023

Conditions

Asthma

Outcome Measures

Primary Outcomes (1)

  • Change from Asthma quality of life between two periods : before intervention and 3 month after the intervention

    The physician gives Asthma quality of life questionnaire (AQLQ) before intervention and 3 month after the intervention

    before and 3 month after the intervention

Study Arms (1)

pregnant women with asthma

Other: follow-up

Interventions

follow-upOTHER

Questionnaire of Quality of life

pregnant women with asthma

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

women with asthma

You may qualify if:

  • Adult pregnant women with asthma

You may not qualify if:

  • women not able to speak and/or read French language
  • women protected by the law

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chu Reims

Reims, 51092, France

Location

MeSH Terms

Conditions

Asthma

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 8, 2022

First Posted

July 14, 2022

Study Start

September 19, 2022

Primary Completion

June 27, 2023

Study Completion

October 31, 2023

Last Updated

November 21, 2023

Record last verified: 2023-10

Locations

FR(1)